COMPANIESTIGERLESS HEALTH INC.
✓ Verified H1B Sponsor

TIGERLESS HEALTH INC.

New York, NYEIN 832718739
TRUST SCORE
85.7
High Trust
6
FY2024 H1B Approvals
6
All-time Approvals
85.7
Trust Score / 100

TOP SPONSORED JOB CATEGORIES

Market Research Analysts and Marketing SpecialistsFinancial and Investment AnalystsWeb and Digital Interface Designers

RECENT H1B FILINGS

JOB TITLELOCATIONWAGEDATE
Market Research Analysts and Marketing SpecialistsNew York, NY$29Sep 2025
Financial and Investment AnalystsNew York, NY$85,301Aug 2025
Public Relations SpecialistsNew York, NY$70,000Aug 2025
Financial and Investment AnalystsNew York, NY$85,301Jul 2025
Market Research Analysts and Marketing SpecialistsNew York, NY$27.3Oct 2024
Web and Digital Interface DesignersNew York, NY$30.58Oct 2024
Market Research Analysts and Marketing SpecialistsNew York, NY$27.3Oct 2024
Web and Digital Interface DesignersNew York, NY$30.58Oct 2024

SHOWING 50 MOST RECENT · SOURCE: DOL LCA PUBLIC DATA FY2024 · EIN 832718739

FREQUENTLY ASKED QUESTIONS

Does TIGERLESS HEALTH INC. sponsor H1B visas?

Yes. TIGERLESS HEALTH INC. has an active H1B sponsorship history with 6 total approved LCA filings on record, including 6 approvals in FY2024. Data sourced from US Department of Labor public disclosure files.

How many H1B visas has TIGERLESS HEALTH INC. sponsored?

According to DOL LCA data, TIGERLESS HEALTH INC. has 6 all-time H1B approvals and 6 approvals in fiscal year 2024.

What types of roles does TIGERLESS HEALTH INC. sponsor H1B for?

TIGERLESS HEALTH INC. most commonly sponsors H1B visas for: Market Research Analysts and Marketing Specialists, Financial and Investment Analysts, Web and Digital Interface Designers. This is based on their DOL Labor Condition Application filing history.

Is TIGERLESS HEALTH INC. a reliable H1B sponsor?

TIGERLESS HEALTH INC. has a Trust Score of 85.7/100 on KEEL, calculated from total approval volume, recency of filings, and approval consistency based on DOL LCA data.

DATA SOURCE: US DEPT. OF LABOR · LCA PUBLIC DISCLOSURE FY2023–FY2024